Skip to content

Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

Multicenter Randomized Controlled Trial (RCT) and Efficacy Evaluation System Study on Surgical Innovation Strategies for Neonatal Complex Congenital Heart Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114625
Enrollment
Unknown
Registered
2025-12-16
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Complex Congenital Heart Disease

Interventions

Experimental Group:Surgical operation is performed on neonates aged 7 days (postnatal age).

Sponsors

Central China Fuwai Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 48 Hours

Inclusion criteria

Inclusion criteria: Part One: 1. Neonates diagnosed with TAPVC, CoA/IAA, TGA, PA/IVS, or severe PS via pre-admission cardiac echocardiography; 2. Patients and families demonstrating high compliance, willing to sign informed consent forms and agree to complete one year of follow-up and related examinations. Part Two: 1. Preterm infants (gestational age <36 weeks at birth) and low birth weight infants (<2.5kg) diagnosed postnatally with TAPVC, CoA, TGA, PA/IVS, or severe PS; 2. Neonates requiring emergency surgery due to persistent instability following medical management postnatally.

Exclusion criteria

Exclusion criteria: Part One: 1. Neonatal age > 48 hours (at admission); 2. Preterm infant (gestational age < 36 weeks at birth); 3. Low birth weight (weight < 2.5 kg); 4. Concurrent severe extracardiac anomalies or complex cardiac malformations; 5. Preoperative respiratory or circulatory instability requiring emergency surgery. Part Two: 1. Concurrent severe extracardiac anomalies or complex cardiac malformations; 2. Incomplete clinical documentation; 3. Legal guardian refuses consent for study enrolment.

Design outcomes

Primary

MeasureTime frame
Perioperative Mortality and Non-Rehabilitation Discharge Rate;

Secondary

MeasureTime frame
The incidence of surgical age < 7 days due to disease necessity in the control group;Postoperative Intensive Care Unit (ICU) Length of Stay;Postoperative Mechanical Ventilation Time;Postoperative Hospital Length of Stay;Incidence of Adverse Events at 12 Months Postoperatively (All-cause Death, Cardiovascular Death, Residual Structural Lesions, Cardiopulmonary Resuscitation, Heart Failure, and Malignant Arrhythmia);

Countries

China

Contacts

Public ContactTaibing Fan

Central China Fuwai Hospital of Zhengzhou University

fantaibing@163.com+86 150 3807 8538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026